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      I enjoy talking with very old people. 
      They have gone before us on a road by which we, too, 
       may have to travel, 
  and I think we do well to learn from them what it is like. 
 
Socrates, in Plato’s The Republic
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Summary 
Aims: The major aims of the present work were to investigate the impact of treatment 
in a geriatric evaluation and management unit (GEMU) as compared to the general 
medical wards (MW) with respect to mortality, place of care delivery, function, morale 
and drug prescription. 
Background: Previous research has shown that hospitalised elderly patients may 
experience underdiagnosis and misdiagnosis, increased risk of iatrogenic conditions, 
and functional decline during the hospital stay. Documentation of treatment effects in 
acutely sick, frail elderly patients in GEMUs is scarce. 
Methods: Acutely sick, frail patients aged 75 years or older were included. These had 
been admitted to different sections of the Department of Internal Medicine as 
emergencies. The patients were randomly assigned either to treatment in the GEMU (n 
= 127) or to continued treatment in the section where they were already staying, defined 
as MW (n = 127). The following inclusion criteria were used to target frail patients: 
chronic disability, acute impairment of single activity of daily living (ADL), 
mild/moderate dementia, confusion, depression, imbalance/dizziness, falls, impaired 
mobility, urinary incontinence, malnutrition, polypharmacy, vision or hearing 
impairment, social problems or prolonged bedrest. In the GEMU interdisciplinary 
assessment of all relevant disorders, prevention of complications and iatrogenic 
conditions, early mobilisation, rehabilitation and discharge planning were emphasised. 
The control group received treatment as usual from the Department of Internal 
Medicine. After discharge neither group received specific follow-up. 
Findings: Mortality in the GEMU and MW groups was 12 % and 27 % respectively at 
three months (p = 0.004), 16 % and 29 % at six months (p = 0.02), and 28 % and 34 % 
(p = 0.06) at 12 months. The hazard ratio (HR) was 0.39 (95% CI 0.21 - 0.72) at three 
months. Heart disease was the major cause of death in both groups at both three and 12 
months. At 12 months deaths from infections (mainly pneumonia) were more frequent 
in the GEMU group than in the MW group (p = 0.04). Length of hospital stay was 
longer in the GEMU than in the MW. There was no difference regarding place of care 
delivery in the two groups after discharge from hospital during six months of follow-up. 
Of all subjects recruited to the study, more GEMU than MW patients were still living in 
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their own homes at three and six months. The HR of living at home versus living in 
nursing homes or having died, was 2.1 (95% CI 1.3 - 3.4) after three months, and 1.6 
(95% CI 1.1 - 2.5) after six months. Treatment in the GEMU had no measurable effect 
on physical function, cognition, symptoms of depression or morale during 12 months of 
follow- up as compared to treatment in the MW. If the dead were included in the 
analysis at the highest ADL dependency level, there was better function in the GEMU 
group at three months. The median number of scheduled drugs withdrawn and started 
per patient was higher in the GEMU than in the MW. Drugs with anticholinergic 
effects, cardiovascular drugs, particularly digitalis glycosides, and antipsychotic drugs, 
were withdrawn more often, while antidepressants and oestriol were started more often 
in the GEMU than in the MW. Fewer GEMU than MW patients had potential drug-drug 
interactions at discharge.  
Conclusion: Treatment in the GEMU considerably reduced mortality as compared to 
treatment in the MW. Except for a longer duration of hospital stay in the GEMU group, 
there were no group differences regarding place of care delivery, function or morale 
among the survivors. If the dead were included in the analyses, patients treated in the 
GEMU had increased possibilities of living in their own homes during six months of 
follow-up and better function at three months. Drug treatment seemed to be more 
appropriate in the GEMU than in the MW. 
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1.0 Introduction 
1.1 General aspects 
In all parts of the world, the industrialised countries in particular, the population is 
growing older (Butler, 1997; Carpenter, 2005). The over-65s account of the populations 
is expected to increase considerably during the next decades (Figure 1) (Waaler, 1999; 
Ellis and Langhorne, 2004). In Norway 14% of the population was 67 years or older in 
2004. This is expected to increase to about 19 - 22% in 2050. The number of persons 
over 67 years will double during this period, especially the number of persons over 90 
years will increase (Figure 2) (Waaler, 1999; Statistisk sentralbyrå, 2005). 
 
Longitudinal studies from industrialised countries indicate that elderly preserve health 
and function better now than they did 30 years ago (Manton et al., 1997; Andrews, 
2001; Cutler, 2001; Freedman et al., 2002; Fries, 2002). Nevertheless, the number of 
elderly patients with chronic disorders is expected to increase. This is related to higher 
prevalence of chronic disorders among elderly as well as improved medical treatment 
that has reduced mortality of patients with disorders like heart failure and cancer (Khaw, 
1997; Waaler, 1999; Mor, 2005). 
 
Hospital admissions for emergencies have continued to increase year by year and is 
expected to increase even more with the largest increase among the elderly (Ellis and 
Langhorne, 2004; Jørgenvåg, 2005). In 2003 the 5% of the Norwegian population over 
80 years caused 21% of all emergency admissions to somatic hospitals (Jørgenvåg, 
2005). The number of early readmissions is also increasing, especially among those 
over 80 years (Jørgenvåg, 2005).  
 
Hospitalised elderly are characterised by atypical symptom presentation, multi-
morbidity and impaired cognitive and physical function (Levkoff et al., 1988; Jarrett et 
al., 1995; Waaler, 1999; Grimley Evans, 2000; Rø, 2000). During hospital stays they 
are at high risk of deconditioning and increased functional impairment, having  
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Figure 1. Number of persons over 65 years in Norway from 2000 to 2050 (Waaler, 1999) 
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Figure 2. Expected change in the population over 70 years (%)  (Waaler, 1999). 
 
Both figures are reprinted with permission from the Norwegian Ministry of Health and Social 
Affairs (Waaler 1999). 
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increased risk of adverse hospital outcomes such as increased length of stay (LOS), 
nursing home placement and death (Gillick et al., 1982; Harper and Lyles, 1988; 
Hoenig and Rubenstein, 1991; Creditor, 1993; Sager et al., 1996; Fortinsky et al., 
1999). Iatrogenic complications and adverse drug events are common (Gorbien et al., 
1992; Lefevre et al., 1992; Ebbesen et al., 2001), but seem at least to be partly 
preventable (Leape et al., 1991; Rothschild et al., 2000).  
1.2 Comprehensive geriatric assessment (CGA)  
The basic principles of geriatric medicine were created in UK by Marjory Warren 
(1897-1960) who during the 1930s was in charge of a large chronic disease hospital 
filled with bedfast, neglected elderly patients. Marjory Warren introduced one of the 
cornerstones in modern geriatric medicine, the comprehensive geriatric assessment 
(CGA). Her approach towards these patients included individual assessment of needs, 
treatment matching these needs, improved environment for patients and staff, active 
rehabilitation and increased attention to these patients. This attitude soon showed to be 
beneficial in that many of the patients got out of bed, and some could even be 
discharged home (Grimley Evans, 1997).  
 
CGA has become a fundamental component of geriatric care due to the complexity of 
the frail elderly patients who requires a multidimensional approach to obtain optimal 
diagnoses and treatment plans (Rubenstein et al., 1991). CGA is a systematic, 
multidimensional diagnostic process focusing on evaluation of a frail elderly person’s 
medical, psychosocial and functional capabilities and limitations in order to develop a 
coordinated and integrated plan for treatment and long-term follow-up, including 
appropriate rehabilitation (Rubenstein et al., 1991; Rubenstein et al., 1995; Elon et al., 
2000; Sletvold et al., 1996; Ellis and Langhorne, 2004). The goal of the CGA is 
accurate multidimensional diagnoses in order to improve care outcomes and quality of 
life for frail elderly (Rubenstein et al., 1991). CGA has a number of major measurable 
dimensions, usually grouped into: physical health, functional status, psychological 
health and socio-/environmental parameters (Rubenstein, 1995). 
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1.3 In-hospital geriatric treatment 
In general two models of in-hospital geriatric intervention have been described for high 
risk elderly patients: 1) A multidisciplinary geriatric consultation team that makes a 
systematic assessment of the patients and recommends a plan of treatment (Ellis and 
Langhorne, 2004). 2) Treatment of patients in geriatric evaluation and management 
units (GEMUs). A GEMU is a ward admitting frail elderly in-patients for a process of 
systematic multidisciplinary assessment, review and therapy (Ellis and Langhorne, 
2004). GEMUs have been crucial in developing basic concepts of CGA. During the last 
ten years another kind of in-hospital wards has been introduced, the Acute Care for 
Elders units (ACE) (Palmer et al., 1998). These are units designed to prevent functional 
decline in hospitalised elderly in general. The ACE model is characterised by prepared 
environment, patient centred care by primary nurse, interdisciplinary team rounds and 
medical care reviews. Later in this thesis ACE and GEMU studies will both be referred 
to as GEMU studies. 
 
Early uncontrolled studies on the effectiveness of in-hospital geriatric assessment and 
treatment were performed on both interdisciplinary teams and treatment in GEMUs. 
Many of them showed beneficial effects of the treatment in terms of improved 
diagnostic accuracy (Rubenstein et al., 1981; Applegate et al., 1983; Rubenstein et al., 
1987), reduced discharge to nursing homes (Sloane, 1980; Applegate et al., 1983; 
Lefton et al., 1983), improved functional status (Rubenstein et al., 1981; Applegate et 
al., 1983; Rubenstein et al., 1987), improved cognition (Applegate et al., 1983), and 
reduced medication (Rubenstein et al., 1981; Rubenstein et al., 1987).  
 
Randomised clinical studies (RCTs) on the effect of geriatric consultation teams have 
shown conflicting results, but generally no or small effects have been found (Stuck et 
al., 1993; Naughton et al., 1994; Reuben et al., 1995).  
 
Before the present study was performed a meta-analysis of the effectiveness of 
treatment in GEMUs as compared to usual care was published (Stuck et al., 1993). Six 
studies of treatment in GEMUs were included in the analyses (Teasdale et al., 1983; 
Rubenstein et al., 1984; Gilchrist et al., 1988; Applegate et al., 1990; Powell and 
 15 
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Montgomery, 1990; Harris et al., 1991). Only one of these concerned acute medical 
diseases (Harris et al., 1991), and one has only been published as an abstract (Powell 
and Montgomery, 1990). Four were rehabilitation studies of which only two were RCTs 
including general high risk elderly patients (Rubenstein et al., 1984; Applegate et al., 
1990), one was done in an orthogeriatric unit (Gilchrist et al., 1988) and one did not use 
a randomised design (Teasdale et al., 1983). In the meta-analysis it was concluded that 
treatment in GEMUs reduced six-month mortality (OR 0.65, 95% CI 0.46 - 0.91). 
Further it increased the chance of living at home versus being dead or in nursing homes 
at six months (OR 1.8, 95% CI 1.28 - 2.53) and 12 months (OR 1.68, 95% CI 1.17 -
2.41). In addition, it was concluded that treatment in GEMUs improved physical 
function at six and 12 months and cognitive function at six months. The magnitude of 
these effects was not specified.  
 
As mentioned above only three single randomised clinical studies on treatment in 
GEMUs had been published when the present study was planned (Rubenstein et al., 
1984; Applegate et al., 1990; Harris et al., 1991). Later results from four studies have 
been published (Landefeld et al., 1995; Asplund et al., 2000; Counsell et al., 2000; 
Cohen et al., 2002) (Table 1), one of them being a multi-centre study (Cohen et al., 
2002).  
 
Rubenstein, Applegate and Cohen performed studies in a subacute setting; they 
included patients who had been stabilised after admission for acute disorders 
(Rubenstein et al., 1984; Applegate et al., 1990; Cohen et al., 2002). Patients in these 
studies were also targeted for frailty, and those who were too healthy or too ill were 
excluded. The study of Harris, Landefeld, Asplund, and Counsell were all performed in 
acute care settings recruiting patients with non-elective admissions, excluding those in 
need of any kind of specialised treatment (Harris et al., 1991; Landefeld et al., 1995; 
Asplund et al., 2000; Counsell et al., 2000).  
 
In most of these studies the intervention is briefly described with few details. All studies 
performed CGA and rehabilitation, and they had multidisciplinary teams that in most 
cases were staffed with a geriatrician, trained nurses, physiotherapists, occupational  
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therapists, dietetics, and social workers (Table 1). In most studies the teams had regular 
meetings with goal setting at least once a week. Two of the studies described that 
implementation of nursing protocols was emphasised (Landefeld et al., 1995; Counsell 
et al., 2000). In the studies of Rubenstein and Cohen an outpatient geriatric follow-up 
was given after discharge from hospital (Rubenstein et al., 1984; Cohen et al., 2002). 
Only in the study of Cohen a two by two factorial study design made it possible to 
distinguish between effects of CGA offered in the GEMU and that offered after 
discharge. 
  
In four of the studies function was improved in the intervention group as compared to 
the control group (Rubenstein et al., 1984; Applegate et al., 1990; Landefeld et al., 
1995; Cohen et al., 2002). Discharges to nursing homes were reduced in two studies 
(Rubenstein et al., 1984; Landefeld et al., 1995), and the number of nursing home days 
during one year of follow-up was reduced in two of the studies (Rubenstein et al., 1984; 
Applegate et al., 1990). Two studies improved morale or health related quality of life 
(Rubenstein et al., 1984; Cohen et al., 2002). Only one study demonstrated statistically 
significant reduced mortality (Rubenstein et al., 1984), while another had a 50% 
reduction in mortality without achieving statistical significance (Applegate et al., 1990). 
One study found reduced number of readmissions to hospital (Rubenstein et al., 1984), 
and one reduced LOS (Asplund et al., 2000). Improved process of care and provider 
satisfaction in the intervention group, was shown in the study of Counsell (Counsell et 
al., 2000).  
1.4 Separate components of CGA 
CGA is directed towards prevalent and frequently overlooked conditions in frail elderly. 
The components most commonly included in the CGA are physical function, 
medication, nutrition, pain, urinary incontinence, constipation, vision and hearing, 
cognition, depression, socio-environmental factors and discharge planning (Rubenstein 
et al., 1995; Elon et al., 2000).  
 
Assessment of physical function often includes ADL, IADL and mobility (Pearson, 
2000). Deterioration in ADL often accompanies illness in frail elderly (Harper and 
 19 
Lyles, 1988). Assessment of ADL has been shown to give clinical important 
information beyond that provided by laboratory data and comorbidity indexes 
(Covinsky et al., 1997). Patients with impairments in ADL before hospitalisation have 
increased risk of further loss of function during the hospital stay (McVey et al., 1989; 
Sager et al., 1996; Fortinsky et al., 1999). Further, impairments in ADL is predictive for 
increased LOS, increased risk of hospital complications, readmissions, nursing home 
placement and mortality (Donaldson et al., 1980; Becker et al., 1987; Narain et al., 
1988; Rowland et al., 1990; Mayer Oakes et al., 1991; Covinsky et al., 1997; Ponzetto 
et al., 2003; Rozzini et al., 2005). All RCTs on treatment in GEMUs that targeted frail 
elderly have used impaired ADL as one of their inclusion criteria (Rubenstein et al., 
1984; Applegate et al., 1990; Cohen et al., 2002). Four RCTs on efficacy of treatment 
in GEMUs and the metaanalyses of Stuck showed improvement in ADL by treating 
patients in GEMUs (Rubenstein et al., 1984; Applegate et al., 1990; Stuck et al., 1993; 
Landefeld et al., 1995; Cohen et al., 2002).  
 
Impaired mobility is a risk factor for falls which is common among hospitalised elderly 
(Evans et al., 2001). Assessments and interventions to prevent falls have been shown to 
be efficient among those living in the community (Gillespie et al., 2003) and in nursing 
homes (Becker et al., 2003). There are also a few studies showing beneficial effects of 
interventions on falls within hospitals (Evans et al., 2001; Haines et al., 2004), but 
further research is needed (Gillespie, 2004). Two GEMU studies showed that CGA 
improved mobility (Counsell et al., 2000; Cohen et al., 2002), but none of these used 
falls as an endpoint. 
 
Hospitalised frail elderly patients often suffer from cognitive impairment, mostly due to 
delirium, dementia or delirium on dementia. In the study of Rø on hospitalised patients 
75 years or older, 41% had one or more symptoms of impaired cognition (Rø, 2000). 
The occurrence rate of delirium among hospitalised elderly in other studies has varied 
between 14 - 56%. Delirium is related to several adverse outcomes like increased LOS, 
poor functional status, increased risk of nursing home placement and death (Cole and 
Primeau, 1993; McCusker et al., 2001; Inouye, 2004). It is frequently overlooked by 
doctors and nurses, if not systematically screened for (Laurila et al., 2004). Research 
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has shown that the implementation of a systematic program to identify and prevent 
delirium may be efficient (Inouye et al., 1999; Anderson, 2005), while evidence for 
efficient treatment strategies is still lacking (Britton and Russell, 2004). No single RCT 
of treatment in GEMUs has shown effect on cognition, while in the metaanalysis of 
Stuck treatment in GEMUs was shown to improve cognitive function at six months 
(Stuck et al., 1993). 
 
About 5-10% of elderly outpatients have depression (Alexopoulos et al., 2002), and the 
prevalence seem to be higher for patients who are referred to hospitals (Ames and 
Tuckwell, 1994). Depression is frequently overlooked in the elderly (Meldon et al., 
1997). Depression has negative impact on patients’ quality of life and increase suicidal 
risk. Both milder depressive symptoms and symptoms fulfilling the diagnostic criteria 
for depression may increase disability (Covinsky et al., 1997; Lyness et al., 1999; 
Alexopoulos et al., 2002). Adequate pharmacological and non-pharmacological 
treatment can be efficient, and may improve both symptoms of depression and function 
(Borson et al., 1992; Bartels et al., 2002). In the study of Counsell depression was 
recognised more often in the GEMU as compared to usual care (Counsell et al., 2000). 
In the study of Landefeld depression scores was lower at discharge in the intervention 
group (Landefeld et al., 1995). 
 
Although assessment of nutrition is one component of CGA, none of the RCTs have 
reported outcomes related to nutrition. Malnutrition is common among frail elderly 
(Pirlich and Lochs, 2001), and is associated with decreased immune function, pressure 
ulcers, frailty, hip fractures, increased LOS and increased mortality (Morley, 2003). 
Risk factors for malnutrition in the elderly are somatic disorders, dental problems, 
immobility, drugs, dementia, depression, social isolation, and problems preparing food 
(Pirlich and Lochs, 2001). Most causes are reversible and treatment has to be directed 
towards the underlying factors (Morley, 2003). Treatment with nutritional supplements 
has been shown to produce a small but consistent weight gain in older people (Milne et 
al., 2005), and vitamin D supplementation has been shown to have positive impact on 
neuromuscular function and incidence of falls (Venning, 2005). Furthermore, social 
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support enhanced food intake in both home-dwelling and nursing home patients 
(Simmons et al., 2001; Suda et al., 2001). 
 
One of the goals of CGA is to improve patients’ quality of life. General well-being has 
been an endpoint in two studies (Rubenstein et al., 1984; Asplund et al., 2000). One of 
these found that GEMU treatment had beneficial effects (Rubenstein et al., 1984). The 
study of Cohen was the only study measuring health related quality of life ( SF-36) 
(Cohen et al., 2002). Improvements in the four subscales measuring physical function, 
bodily pain, energy and general health were observed at discharge. With reference to 
other studies it was concluded that the magnitude of these changes were clinically and 
socially meaningful. The finding of improved score on bodily pain is important, as pain 
has been shown to be prevalent among frail elderly and is associated with impaired 
mood, depression, impairments in ADL, and decreased activity involvement (Won et 
al., 1999; Onder et al., 2005). Under-treatment of pain has been shown to be common, 
especially among the oldest and those with dementia (Landi et al., 2001).  
 
Urinary incontinence has been identified as a problem in 24 -33% of all medial in-
patients over 75 years (Ouslander J.G., 2000; Rø, 2000). This problem is often 
experienced as embarrassing and may have adverse effects on physical health, social 
life, mood and quality of life. In addition it is costly. The pathogenesis for urinary 
incontinence among elders is often multifactorial. Important risk factors are cognitive 
impairment, mobility problems, disorders in the lower urinary tract, increased urinary 
production (drugs, diabetes) and adverse drug reactions (Ouslander J.G., 2000). The 
identification of potentially reversible factors is important. Behavioural, pharmacologic 
and surgical interventions may help. None of the RCTs on treatment in GEMUs have 
focused on urinary incontinence. 
 
There is little research on how the structure and organisation of GEMUs should be. In 
general, a broad approach towards the elderly patients seems to be sensible. Therefore 
the GEMU staff should represent a multidisciplinary team. Furthermore the 
environment has to be designed and organised for an elderly population, and findings of 
CGA should lead to the implementation of coordinated plans for the management of 
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individual patients. Studies focusing on single elements of structure and organisation 
are generally lacking, except for the study of Counsell (Counsell et al., 2000) where the 
process of care and provider satisfaction was better in the GEMU as compared to 
conventional care.  
 
The methods for assessment vary, but often one or more sets of instruments to assess 
functional, psychological and social status are employed (Rubenstein et al., 1991). Use 
of assessment scales has been recommended in daily practice. They are more sensitive 
than clinical judgement in detecting moderate impairments, valuable in individual care 
planning, and improve quality of care. In addition, they give important information 
about progress in hospitalised patients, and enlighten research (Pinholt et al., 1987; 
Schroll, 1997; Phillips et al., 1997; Poulsen et al., 2005).  
 
Discharge planning has been described as a key element in all RCTs on treatment in 
GEMUs, but none of them were designed to evaluate the effectiveness of discharge 
planning. Two systematic reviews on this topic have excluded GEMU studies (Parker et 
al., 2002; Shepperd et al., 2004). The reviewers conclude that there are generally few 
studies on discharge planning, and most of those which exist are from USA. Most 
studies have excluded patients being cognitively impaired. Endpoints studied were 
mortality, LOS and readmissions to hospital, while patient and caregiver satisfaction, 
physical or cognitive function or quality of life have not been assessed. The reviews 
concluded that comprehensive discharge planning can have beneficial effects on 
subsequent readmission rates, especially if intervention is given both at the hospital and 
in the patients’ homes.  
 
The intervention performed in the GEMU has often been characterised as a “black box” 
intervention, meaning that we do not know which elements are important or efficient. 
As shown above we definitely have some evidence that can shed a little light into this 
black box. There is extensive research going on within most of the areas described 
above. 
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1.5 Drugs  
There is little evidence about the effect of drug treatment in frail elderly patients 
because they are often excluded from clinical trials (Le Quintrec et al., 2005; McMurdo 
et al., 2005). Nevertheless, the prevalence of chronic disorders is high in the elderly, 
and they are often using many different drugs concurrently (Beers et al., 2000). The 
intention of pharmacotherapy is to improve health, function and quality of life in 
addition to prevention of diseases. But, drug treatment in these patients may be a 
complex issue due to diminished physiologic reserves and age-related changes in 
pharmacokinetics and pharmacodynamics (Meyer, 2000). Adverse drug reactions 
(ADRs) are common among frail elderly with high comorbidity, those who are using 
many different drugs, or specific types of drugs (Carbonin et al., 1991; Hanlon et al., 
2003; Ruths et al., 2003). Many admissions to hospital are related to ADRs, of which 
some may even be fatal (Lazarou et al., 1998; Ebbesen et al., 2001; Onder et al., 2002; 
Pirmohamed et al., 2004). There are several reasons for ADRs, such as overuse of 
drugs, inappropriate use, or poor adherence to treatment recommendations (Kelly and 
Chamber, 2000; Ahmed et al., 2002; Hanlon et al., 2003; Onder et al., 2003; Hanlon et 
al., 2004; Hajjar et al., 2005). Frail elderly patients are also at increased risk of ADRs 
related to withdrawal of drugs, either due to physiological reactions (for example of 
benzodiazepines or beta-blockers) or due to exacerbation of an underlying disease (for 
example increased heart failure when withdrawing diuretics) (Kennedy et al., 2000; 
Petrovic et al., 2002; Hanlon et al., 2003; Ruths et al., 2004). Another problem with 
drug treatment that frequently occurs among elderly patients is therapeutic failure 
leading to lack of disease control and subsequent hospital admissions (Hanlon et al., 
2003). In addition to non-adherence, this may be related to underuse of medications that 
has been shown to be a problem in the elderly for example during treatment of heart 
failure (Gattis et al., 1998; Ruths et al., 2000). 
 
Treatment in GEMUs has been shown to reduce polypharmacy (Rubenstein et al., 1984; 
Owens et al., 1990; Kruse et al., 1991), the frequency of adverse drug reactions 
(Carbonin et al., 1991), prescription of inappropriate and unnecessary drugs (Owens et 
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al., 1990; Carbonin et al., 1991; Counsell et al., 2000; Schmader et al., 2004) and 
underuse of drugs (Schmader et al., 2004). 
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 2.0 Aims 
 
The aim of this thesis is to compare the effect of treating patients in a Geriatric 
Evaluation and Management Unit (GEMU) with care delivered at other sections in a 
Department of Internal Medicine (DIM), defined as general Medical Wards (MW). 
 
More specific the purposes are to assess the effect on 
 
o Mortality 
o Place of care delivery after inclusion 
o Function and morale 
o Drug prescription 
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3.0 Material and methods 
3.1 Local background for the study 
The trial on which this thesis is based, was performed at the University Hospital of 
Trondheim that serve not only as the regional hospital for Central Norway, but also as 
the local hospital for about 200 000 inhabitants in the county of Sør-Trøndelag, 
Norway.   
 
For many years there had been a problem that many patients defined ready for 
discharge, actually could not be discharged due to lack of nursing home beds in the 
municipality of Trondheim. Generally, these were elderly patients admitted to hospital 
due to acute disorders, but characterised by several comorbidities as well as physical 
and cognitive impairments. Before 1994 there was no specialist service for geriatric 
patients, neither in-hospital nor community-based.  
 
In 1993, aiming for better collaboration on geriatric patients across administrative 
sectors, the hospital and the municipality applied for funding of a GEMU. The 
Norwegian Ministry of Health and Social Affairs gave support for the establishment and 
scientific evaluation of such a unit. Another important promoter of the study was the 
experience from a RCT on the efficacy of treatment in a Stroke Unit that had been 
performed at the Department of Internal Medicine (DIM) a few years earlier (Indredavik 
et al., 1991). 
 
A nine-bed GEMU was established in April 1994. The GEMU was a section of the DIM 
that already had eight different sections within other branch specialties of internal 
medicine and a total of 190 beds. Over 90% of all admissions were emergencies. The 
period from April to October 1994 was a run-in period in the GEMU with focus on 
training of employees and establishing routines for assessment and treatment.  
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3.2 Conventional (control) care 
In the present study general medical wards (MW) have been defined as all wards in the 
DIM except the GEMU. Conventional (control) care is defined as treatment given in the 
MW. The care at the DIM was given according to the general protocol for the DIM and 
guidelines within internal medicine. Except for the GEMU and Stroke Unit, there was 
no dedicated program at the hospital focusing on the handling of frail elderly patients 
with high degree of comorbidity.  
 
In the MW residents and specialists in internal medicine and different branch specialties 
were responsible for the medical treatment provided together with nurses and enrolled 
nurses (Table 2). Doctors and nurses had meetings concerning all patients of the ward 
every morning. Physiotherapy and occupational therapy were normally given when 
prescribed by the doctor, each occupational therapist and physiotherapist was serving 
several wards. In most cases the cooperation between physiotherapists, occupational 
therapists and the rest of the staff in the MW was not systematically organised. When 
the MW patients were referred for consultation by the geriatrician, this was performed 
according to general routines of the GEMU. Home care nurses were telephoned to 
discuss arrangements after discharge only if the hospital staff found it necessary.  
 
The DIM had educational programs for residents who were specialising within internal 
medicine and in branch specialties of internal medicine including geriatrics.  
 
3.3 The geriatric evaluation and management unit (GEMU) 
3.3.1 Organisation 
The physical environment in the GEMU was comparable to that in other medical wards, 
apart from an additional combined dining/activity-room. As far as possible an 
“enriched” environment was created to enlighten the patients’ orientation (Inouye, 
2004). This included visible calendars and clocks in all rooms, naming plates and signs 
on the doors, sufficient lightening, and access to necessary aids (including hearing aids) 
and to news (television, newspapers, and magazines). 
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 Table 2. Comparison of staff and patient approach between the GEMU and the MW. 
GEMU (9 beds) MW 
Staff  
Some nurses with formal training in geriatric 
nursing* 
Enrolled nurses 
One geriatrician* 
One (sometime two) residents* 
Two occupational therapists* 
One physiotherapist* 
Same number of nurses as the GEMU 
 
Enrolled nurses 
Branch specialists of internal medicine 
One resident per 5-10 beds 
½ occupational therapist per 180 beds 
Five physiotherapist serving about180 beds 
Intervention Conventional care 
Medical treatment according to general 
guidelines 
Interdisciplinary assessment 
Management of all relevant disorders 
Screening  
Orthostatic hypotension 
Drug regimen 
Malnutrition  
Urinary incontinence 
Constipation 
Function (cognition, ADL, IADL) 
Gait, balance and mobility 
Depression  
Vision and hearing 
Social problems/ caregiver burden 
Prevention of iatrogenic conditions and 
complications 
Early mobilisation and rehabilitation 
Discharge planning  
Visit in patients’ homes if indicated 
Medical treatment according to general 
guidelines 
Assessment mainly by doctors and nurses 
Mainly management of diseases 
precipitating the emergency admission  
 
*Also performing study related assessments in both groups during index stay and follow-up. 
GEMU= Geriatric Evaluation and Management Unit, MW= General Medical Wards, ADL= 
Activities of Daily Living, IADL= Instrumental Activities of Daily Living.  
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 The number of nurses and enrolled nurses employed in the GEMU was comparable to 
that in MW, some of those employed in the GEMU had formal training in geriatric 
nursing. In addition, the GEMU had two occupational therapists and one 
physiotherapist. One geriatrician and one (occasionally two) residents were responsible 
for the medical treatment in the GEMU (Table 2). During nights, week-ends and 
holidays residents working at the DIM were responsible for the medical service of the 
GEMU patients. When needed, other specialists, a social worker or dentist was 
consulted.  
 
An interdisciplinary approach was employed with close collaboration between all 
disciplines involved. The nurses and doctors had formal meetings discussing all patients 
every morning. Interdisciplinary team meetings were arranged twice a week to report 
assessments, set goals, discuss problems and plan discharge. There were also frequent 
informal meetings where specific tasks were discussed.  
 
Patient and family involvement was encouraged. Both patients and caregivers got 
information regularly during the whole stay in the GEMU and at discharge. As soon as 
possible after admission Home services were called by a nurse to get further 
information about patients’ background and living conditions. Before discharge 
meetings were arranged for the majority of the patients to discuss necessary 
arrangements after discharge. In most cases the patient, caregivers, a representative 
from the Home services and GEMU staff participated.  
 
The collaboration with the general practitioners (GPs) was deficient. Initially a letter 
was sent to the GPs informing that their patients were admitted to the GEMU, and with 
an invitation to contact the GEMU to discuss further treatment. As there was hardly any 
response, this system was discontinued after three to four months. In some cases the 
doctors of the GEMU called the GPs to discuss specific patients who needed specific 
medical follow-up by their GPs after discharge. 
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 The GEMU had a multidisciplinary educational program 45 minutes per week 
consisting of lectures on central issues within geriatric medicine for all members of the 
staff. In addition, the doctors had an educational program 45 minutes every morning 
within geriatrics and internal medicine. 
 
3.3.2 Assessment and treatment 
The treatment in the GEMU consisted of both CGA and conventional medical treatment 
focusing on both the acute medical problems that precipitated the hospital admission 
and other relevant illnesses i.e. medical conditions that seemed to affect the patients’ (or 
caregivers’) function or quality of life (Sletvold et al., 1996).  
 
The medical history of the patients was obtained through previous medical records and 
interviews with patients and caregivers. In addition to a medical history concerning 
acute and chronic illnesses, patients, caregivers and Home services were questioned 
regarding the social situation, physical and cognitive function, drug regimens, nutrition, 
urinary incontinence, constipation and depression before admission to hospital.  
 
A thorough clinical work-up and inspection of the skin, neurological examination, 
assessment of vision and hearing and digital examination of rectum was performed in 
all patients. Body mass index was calculated; blood pressure was measured with the 
patient supine, sitting and standing after two minutes. Physical function including gait 
and balance, ADL and instrumental ADL (IADL) was evaluated. The GEMU staff 
performed observations of the patients with respect to physical function, ADL, eating 
habits, elimination, cognition, mood and behaviour. Patients having problems related to 
their urinary bladder were always examined for residual urine. Standard study related 
assessments with respect to ADL, IADL, cognition and symptoms of depression were 
also used in the clinical evaluation of each patient. Drug regimens were continuously 
evaluated with respect to side-effects, efficacy, appropriateness, doses, interactions and 
compliance. 
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 Further examinations and medical management were performed if appropriate 
according to general guidelines within geriatric medicine and internal medicine and in 
concordance with the patients’ (and caregivers’) wishes.  
 
For all patients prevention of iatrogenic conditions and complications including further 
functional loss were considered important. Early mobilisation and encouragement to 
participate in ADL and communal meals were instituted to prevent functional decline. 
When necessary, relevant rehabilitation measures were initiated in the GEMU. In 
general the rehabilitation aimed at improving ADL, walking on level surface and in 
stairs, and improvement of muscle strength and balance. In addition, adaptation and 
adjustments of necessary aids were important. Individual rehabilitation plans were made 
for each patient to restore function and ensure continuity of treatment. These plans were 
implemented by the physiotherapists, nurses and enrolled nurses to ensure mobilisation 
throughout the day and also during holidays. If further rehabilitation was indicated and 
the patients’ seemed to benefit from the rehabilitation in the GEMU, they were referred 
to specialist rehabilitation facilities after discharge.  
 
Discharge planning started as early as possible, and discharge destination was discussed 
in the first interdisciplinary meeting. Decision on discharge destination was based upon 
the assessments in the GEMU, reports from the Home services, and the patients’ and 
caregivers’ wishes. If the patients were to be discharged home, necessary aids, 
environmental adjustments and assistance were discussed. When necessary, nurses or 
occupational therapists arranged visits to the patients’ homes to evaluate their capability 
to live at home, and whether technical arrangements, aids or assistance from the Home 
services were required. 
 
3.4 Patient care during follow-up 
After discharge from the hospital the responsibility for follow-up was transferred to the 
primary health care system and none of the groups received systematic follow-up from 
the hospital. Responsible for the nursing care in the community health care system in 
Trondheim at the time of this study were the Home services which mainly employed 
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 nurses, enrolled nurses and nursing assistants, but also physiotherapists and 
occupational therapists. The nursing care could be organised in the patients’ own homes 
or in nursing homes. Representatives from the Home services decided which patients 
needed to stay in nursing homes for both the GEMU and MW groups. The GPs were 
responsible for the medical treatment for home-dwelling patients in both groups, while 
nursing home doctors were responsible for nursing home patients.
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 3.5 Study design 
3.5.1 Patient selection 
Patients were enrolled between October 31, 1994 and November 13, 1995. 
 
For practical reasons (geographical distances from the hospital when performing follow-
up assessments and collaboration with only one municipality) only patients admitted as 
emergencies to the DIM from the municipality of Trondheim were screened for 
enrolment into the study. If more patients were eligible for the study, priority was put on 
those who had been admitted most recently. Patients planned to be discharged within 
three days were not included. 
 
The intention was to target frail patients who were neither too sick nor too healthy, as 
these were thought to benefit the most from the intervention in the GEMU. As a 
measure of frailty Winograd’s targeting criteria were applied. Eligible patients had to 
meet at least one of the following targeting criteria: acute impairment of single ADL, 
imbalance/dizziness, impaired mobility, chronic disability, prolonged bedrest, falls, 
confusion, depression, mild/moderate dementia, weight loss, malnutrition, vision or 
hearing impairment, urinary incontinence, social/family problems or polypharmacy  
(Winograd et al., 1991). Previously independent patients who seemed to recover on a 
traditional medical treatment, were not included. Excluded were also patients who were 
staying in nursing homes, those who had known severe dementia with need of 
supervision or help 24 hours a day, and patients who had known terminal illness with 
life expectancy less than six months, including known cancer with metastases (Table 3).  
 
Some patients were of course in need of specific treatment offered by the section to 
which they were already admitted. Therefore, the doctor on the ward had to approve 
before patients could be included. Patients with acute stroke were only included if the 
Stroke Unit was full and the patients had problems additional to their stroke making 
them eligible for the study. 
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Table 3. Inclusion and exclusion criteria 
Inclusion criteria 
I. 75 years or older 
II. Admitted as emergency 
III. Living in Trondheim 
IV. Frail - at least one of the following: 
Acute impairment of single ADL 
Imbalance or dizziness 
Impaired mobility 
Chronic disability 
Weight loss 
Falls during the last 3 months 
Confusion during hospital stay 
Severe vision or hearing impairment 
Depression 
Malnutrition1
Mild or moderate dementia 
Urinary incontinence 2
Social or family problems 
Polypharmacy (≥ 5 drugs per day) 
Prolonged bedrest 
Exclusion criteria 
I. Too healthy: 
Previously independent, no need 
for geriatric assessment  
II. Too sick – at least one of the 
following: 
Nursing home patient 
Severe dementia 3
Terminal illness  
Cancer with metastases 
III. Discharge planned within 3 days 
IV. Need treatment in another ward 
than GEMU 
V. Acute stroke, possibility for 
transfer to the Stroke unit 
1 malnutrition with weight loss, s-albumin < 35 g/l, change in appetite or low body 
weight, 2 urinary incontinence developed during the last week, 3 need of care night and 
day  GEMU= Geriatric Evaluation and Management Unit, ADL= Activity of Daily 
Living. 
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3.5.2 Randomisation procedure 
During the study period one experienced study nurse was assigned to organise the study 
and recruit patients. She was responsible for screening and randomisation of 90% of the 
patients. During her holidays, the project leader screened and randomised the remaining 
10%. Suitable patients were screened when there was a free bed in the GEMU. 
Randomisation was executed after patients had given their informed consent. If the 
patient was cognitively impaired a caregiver gave consent.  
 
To ensure allocation concealment (Altman and Schulz, 2001), an independent research 
office used permuted block randomisation with unknown and varied block size to 
produce allocations that were kept in sealed, serially numbered opaque envelopes. 
Block sizes varied randomly between 4 and 10. All envelopes were opened in sequence 
after the patients had given their consent, with at least one independent witness present 
(usually a nurse on the ward where the patient stayed). Both the research nurse and the 
witness signed the result of the randomisation.  
 
During the study period 1426 patients 75 years or older from Trondheim were admitted 
as emergencies to the DIM, of these 254 patients (18%) were recruited and randomly 
allocated, 127 to the GEMU and 127 to continued treatment in the MW. Five patients 
refused to participate in the study. Patients allocated to the GEMU were transferred 
from the MW on the day of inclusion (Figure 3).  
 
3.6 Outcomes 
3.6.1 Baseline characteristics 
Baseline characteristics of the patients were collected before randomisation by 
interviewing nurses at the wards where the patients were first admitted, and through 
interviews with the patients and their caregivers.  
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  37 
Randomised, n=254 
Treatment in GEMU, n=127 Treatment in MW, n=127 
Geriatric intervention Conventional treatment 
Discharge 
Emergency admissions > 75 
years from Trondheim, 
n=1426 
Refused 
participation, n=5 
Not suitable or no 
free bed in GEMU, 
n=1167 
Follow-up  
 (Home services and GPs) 
 
Figure 3. Flow of the study.  
GEMU= Geriatric Evaluation and Management Unit, MW= General Medical 
Wards. GP= General Practitioners. 
 3.6.2 Mortality 
Mortality during one year of follow-up was chosen as the primary endpoint of the 
present study. Information on mortality and causes of death were obtained from the 
official death certificates that were linked to the computerised system of the hospital. 
 
3.6.3 Place of care delivery after inclusion 
Place of care delivery included the following endpoints: LOS, time to and number of 
readmissions to hospital and/or admission to nursing homes, proportion of observed 
time spent in nursing homes, hospital and at home. Information was partly obtained 
from the medical records at the hospital (computerised system), from interviews with 
the patients and caregivers and from the records of the Home services and the nursing 
homes. These registrations were completed two years after the study was finalised.  
 
Originally the plan was to analyse these endpoints for one year of follow up, but due to 
inferior data quality, only results for six months of follow-up were published. Inferior 
data quality was related to patients who were lost to follow-up, records in the 
municipality being insufficient because a new computerised system had been 
established shortly before study start, and patients and/or caregivers who did not 
remember details on stays in nursing homes.  
 
3.6.4 Function and morale 
To assess function and morale, assessment scales that had been used by others and were 
recommended by the British Geriatric Society were used (Dickinson, 1992). As 
measures of physical function Barthel Index (Mahoney and Barthel, 1965) and 
Lawton’s IADL instrument were chosen (Lawton and Brody, 1969). Barthel Index has 
become widely adopted in clinical research as a measure of ADL. This is an ordinal 
scale comprising ten ADLs: feeding, bowel and bladder continence, personal toilet, 
dressing, toilet use, transfer from bed to chair, walking on level surface, going up/down 
stairs and bathing. In this study a widely used modification of the index that includes a 
revised score range of 0 – 20 was used (Collin et al., 1988). The IADL instrument 
 38
 comprised eight activities: ability to use telephone, shopping, food preparation, 
housekeeping, laundry, mode of transportation, responsibility for medications and 
ability to handle finances (Lawton and Brody, 1969).  
 
Cognitive function was assessed by Mini Mental Status Examination (MMSE) (Folstein 
et al., 1975). Montgomery and Åsberg’s Depression Rating Scale (MADRS) 
(Montgomery and Asberg, 1979) was used as screening for symptoms of depression. To 
evaluate morale the Philadelphia Geriatric Center Morale Scale (PGCMS) was used 
(Lawton, 1975; Morris and Sherwood, 1975). 
 
The selection of patients, getting the patients’ and caregivers’ consents and 
randomisation was to be organised during a few hours in the morning. Only one study 
nurse was employed, while several patients had to be screened; up to six were included 
during one day. When the study was designed the intention was that Barthel Index, 
MMSE and MADRS would be baseline characteristics of the patients, i.e. they should 
be assessed before the randomisation of patients. Due to the logistic challenges 
described above, and that the exact methods were not formally specified in the protocol 
Barthel Index, MMSE and MADRS were all performed after the randomisation and 
transfer of the intervention patients from the general ward to the GEMU.  
 
The assessment of Barthel Index during the hospital stay was performed by the 
occupational therapists and physiotherapist employed in the GEMU (three different 
persons) both for GEMU and MW patients. Assessments in the MW were based upon 
self-report; if the patient was cognitively impaired a nurse was asked. In the GEMU the 
assessments were performance-based. The MW patients had priority because they were 
frequently discharged without any notice. The mean time from inclusion to assessment 
was 1.7 days in the MW and 3.5 days in the GEMU. Median Barthel Index scores were 
15 (iqr 11; 19) for GEMU and 14 (iqr 9; 18) for MW patients (p = 0.03). 
 
The MMSE was mainly assessed by the resident(s) in the GEMU group, and by the 
geriatrician in the MW group. In the MW, assessments were done bedside, often in a 
corridor or four-bed room, while in the GEMU the assessment were performed in a 
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 quiet room. It also turned out that the method for asking and scoring had been 
somewhat different. The mean time from inclusion to assessments was 0.9 days in the 
MW and 1.8 days in the GEMU. The median MMSE score was 25 (iqr 20; 28) in the 
GEMU and 22 (iqr 17; 28) in the MW (p = 0.05).  
 
Because assessments had been performed after the randomisation, with different 
methods and timing, Barthel Index and MMSE were disregarded as baseline 
characteristics. However, ADL and cognition are important prognostic factors for 
survival (Campbell et al., 2004). Therefore they were analysed in a Cox model as 
covariates in the survival analyses. When these two covariates were included in the 
analyses, the three-month survival was still statistically significant better in the GEMU 
group, but the p-value changed from p = 0.004 to p = 0.05. 
 
The follow up assessments on MMSE, Barthel Index, IADL, MADRS and PGCMS 
were performed as interviews three, six and 12 months after discharge from the index 
stay by different employees of the GEMU staff. If the patients were not able to answer, 
proxies were interviewed on Barthel Index and IADL. These interviews were performed 
either at the hospital’s outpatient clinic or in the patients’ homes. 
 
3.6.5 Drug prescription 
Drug prescription was registered as scheduled drugs used at the time of inclusion and at 
discharge. The selected endpoints were: number of drugs withdrawn and started, 
number of drugs used per patient, polypharmacy (i.e. five or more drugs used 
concurrently), drug-drug interactions and use of inappropriate drugs. There was a 
special attention towards cardiovascular and psychotropic drugs during the stay in the 
GEMU, and these drugs were explored in detail. Use of drugs was registered by two 
research assistants after the study was finalised. Data were transferred from the medical 
charts to a registration form and classified according to the Anatomical Chemical 
Classification (ATC) (World Health Organisation and Collaboration Center for Drugs 
Statistics Methodology, 1998). Before starting the analyses the data quality was checked 
in 100 patients and found to be correct in over 90%.  
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Table 4. Time of assessments and completeness of data from GEMU (n=127) and MW 
(n=127) patients. 
Time Outcomes GEMU 
n 
MW 
n 
Inclusion Baseline characteristics, drugs 127 127 
Discharge Diagnoses, discharge destination, LOS, drugs 127 127 
3 months 
 
Mortality, causes of death 
Time in nursing homes 
Living location 
Place of care delivery 
Barthel Index, IADL, MMSE, MADRS* 
PGCMS 
127 
116 
126 
126 
89 
74 
127 
109 
123 
125 
68 
60 
6 months 
 
Mortality 
Time in nursing homes 
Living location 
Place of care delivery 
Barthel Index, IADL, MMSE, MADRS* 
PGCMS 
127 
116 
126 
126 
79 
76 
127 
109 
123 
125 
63 
62 
12 months 
 
Mortality, causes of death 
Barthel Index, IADL, MMSE, MADRS* 
PGCMS 
127 
71 
67 
127 
61 
51 
*Compliance for MMSE, IADL and MADRS approximately as for Barthel Index. 
LOS= Length Of Stay, IADL= Instrumental Activity of Daily Living, MMSE= Mini 
Mental Status Examination, MADRS= Montgomery and Åsberg’s Depression Rating 
Scale, PGCMS= Philadelphia Geriatric Center Morale Scale. 
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 3.7 Statistical methods  
3.7.1 Sample size estimations 
An estimate of possible effect size was based upon literature review. Donaldson 
conducted a study of mortality in relation to age and functional capacity, and found a 
one-year mortality among patients in acute and geriatric beds of about 40% if they had 
considerably reduced ADL-scores, and about 30% in patients with moderately reduced 
ADL-scores (Donaldson et al., 1980).  In the study of Rubenstein a 50% reduction of 
one-year mortality was achieved (Rubenstein et al., 1984).  Based on these studies the 
sample size was estimated (Pocock, 1983).  If one-year mortality was 30% in the MW 
patients, to detect a 50% reduction to 15% in the GEMU, with α = 0.05 and power 80%, 
113 patients would be required in each group. For an estimated mortality reduction from 
40% to 20% the sample size would be less. Thus it was decided to recruit patients over 
a one-year period with at least 113 in each group.  
 
3.7.2 Statistical analyses 
The statistical methods are described in each of the four papers. General considerations 
when performing the analyses were that t-test were used for data that were normally 
distributed, Mann-Whitney U-test was used for data that was not normally distributed 
and for ordinal scales. Chi-square test was used to test group differences for categorical 
data. For survival analyses and for analyses of time to event (for example time to first 
nursing home admission) Kaplan-Meier plots and log-rank tests were used. Cox 
proportional hazards analyses were used to estimate hazard ratio (HR). A p-value of less 
than 0.05 was used as indication of statistical significance in paper I - III. In paper IV 
multiple comparisons were performed, therefore a p-value of less than 0.01 was used. 
For statistical analyses SPSS for Windows was employed. 
 
3.7.3 Missing values  
The number of patients registered with complete data varied for the different outcome 
measures as shown in Table 4. Data that could be registered directly from the medical 
records of the hospital were complete, while data based upon interviews or assessments 
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 during follow-up and records in the municipality were not. More details are described in 
each of the papers. To avoid bias and in concordance with general recommendations it 
was decided that data could be used for analyses if available for more than 80% of the 
patients at risk (Schulz and Grimes, 2002). 
 
Missing data for Barthel Index, IADL, MMSE, MADRS, PGCMS were due to missing 
forms or missing items. Forms were missing because patients died, withdrew their 
consent, were lost to follow-up or were too ill. Missing items were due to medical 
conditions that made the complete test impossible, because the patients did not 
understand, or were not able to answer single questions.  
 
The patients who withdrew or were lost to follow up in the two groups did not differ 
with respect to age, gender, living location after three months, or one-year survival. 
 
According to the literature different methods has been used to handle missing values in 
the present study (Curran et al., 1998; Fayers et al., 1998; Schulz and Grimes, 2002). 
Among these were treating the scale as missing, imputation of the mean of the items 
that were available, imputation of the most likely value, and for missing forms by 
imputing different combinations of worst case, best case, the mean for the study 
population and the last value carried forward and sensitivity analyses. The conclusions 
were not affected by the specific method chosen. 
 
3.8 Ethical considerations 
Participation in the trial was voluntary and in accordance with the Helsinki Declaration. 
The Regional Ethics Committee approved the protocol.  
 
Written informed consent was obtained before inclusion in the study. If the patients 
were not able to write, an oral consent was accepted. Many of the patients asked to 
participate were cognitively impaired and not capable of giving their informed consent. 
Therefore a caregiver was asked to give consent on behalf the patients, a method that is 
frequently used, but nevertheless not without ethical scruples.  
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Because the study population was elderly patients frequently suffering from cognitive 
impairment and sensory losses, the written informed consent was formulated with fonts 
that were possible to read and with a limited amount of text. After the study was 
finalised it was discovered that due to inferior quality of data it would be necessary to 
collect information from health registers in the municipality of Trondheim. This was not 
mentioned in the informed consent. With permission from the Norwegian Data 
Inspectorate and the Norwegian Board of Health these data were collected after the 
patients or their caregivers had given their passive informed consent (three patients did 
not give their consent).  
 
A few times, study-related screening by MADRS in the MW group revealed severe 
depressions, sometimes with suicidal thoughts. This was then reported to the physician 
responsible for the patients immediately. While performing assessments in the MW 
group it was sometimes observed that treatment offered in the MW was not optimal. As 
a general rule the responsible physician could refer the patient for a geriatric 
consultation when needed.  
 
3.9 Financial support  
The GEMU was established and run during the study period through support from the 
Norwegian Ministry of Health and Social Affairs. The Research Council of Norway and 
Norwegian University of Science and Technology (NTNU) paid fellowship for the 
author. 
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Table 5. Baseline characteristics 
 
 
      GEMU 
       (n=127) 
        MW  
      (n=127) 
Age - mean ± SD 81.8 ± 4.8 82.4  ± 5.2 
Female - no. (%) 81 (64) 84 (66) 
Widowed / living alone  - no. (%) 93 (73) 85 (67) 
Residence at time of inclusion – no. (%) 
Private home 
Sheltered housing 
 
115 
12 
 
(91) 
(9) 
 
110 
17 
 
(87) 
(13) 
Days in hospital before inclusion – median (iqr) 2 (1 - 5) 3 (1 - 6) 
Targeting criteria1 – no. (%) 
Acute impairment of single ADL 
Imbalance or dizziness 
Impaired mobility 
Chronic disability 
Weight loss 
Falls during the last 3 months 
Confusion 
Vision or hearing impairment 
Depression 
Malnutrition 
Mild or moderate dementia 
Urinary incontinence 
Social or family problems 
Polypharmacy (≥ 5 drugs per day) 
Prolonged bedrest 
 
111 
110 
54 
52 
31 
30 
24 
22 
21 
15 
14 
12 
10 
5 
3 
 
(87)  
(87) 
(43) 
(41)  
(24) 
(24) 
(19)  
(17) 
(17) 
(12) 
(11) 
(9) 
(8) 
(4) 
(2) 
 
109 
108 
59 
58 
20 
32 
31 
28 
24 
13 
18 
11 
7 
5 
3 
 
(86) 
(85) 
(47) 
(46) 
(16) 
(25) 
(24) 
(22) 
(19) 
(10) 
(14) 
(9) 
(6)  
(4) 
(2) 
No. of targeting criteria per patient –  median (iqr) 4 (3 - 5) 4 (3 - 5) 
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Table 5. Baseline characteristics (cont.) 
 GEMU 
(n=127) 
     MW 
   (n=127) 
Previous diagnoses2 – no. (%) 
Heart disease 
Infectious disease 
Gastrointestinal disorder 
Cerebrovascular disease 
Endocrine disease 
Airway disease 
Cancer 
Other 
 
46 
30 
27 
24 
20 
18 
15 
41 
 
(36) 
(24) 
(21) 
(19) 
(16) 
(14) 
(12) 
(32) 
 
58 
21 
22 
17 
16 
9 
12 
44 
 
(46) 
(17) 
(17) 
(13) 
(13) 
(7) 
(9) 
(35) 
No. of drugs used continuously per patient - median (range) 4 (0-11) 4 (0-11) 
No. of patients (%) using drugs continuously with effect on 
Gastrointestinal system and diabetes (ATC class A) 
Blood and blood building organs (ATC class B) 
Cardiovascular system (ATC class C)3
Urogenital system, sex hormones (ATC class G) 
Endocrine system (ATC class H) 
Systemic infections (ATC class J) 
Muscle and  skeletal system (ATC class M) 
Central nervous system  (ATC class N) 
Respiratory system (ATC class R)  
 
57 
68 
80 
8 
17 
32 
8 
39 
21 
 
(45) 
(54) 
(63) 
(6) 
(13) 
(25) 
(6) 
(31) 
(17) 
 
65 
68 
97 
8 
15 
40 
16 
32 
21 
 
(51) 
(54) 
(77) 
(6) 
(12) 
(31) 
(13) 
(25) 
(17) 
1 Winograd’s targeting criteria (Winograd et al., 1991), 2diagnoses at earlier admissions 
to the University Hospital of Trondheim, 3p = 0.02, else there were no statistically 
significant differences. GEMU = Geriatric Evaluation and Management Unit, MW = 
General Medical Wards, SD = standard deviation, iqr = interquartile range, ADL = 
Activity of Daily Living, ATC = Anatomical Therapeutic Chemical classification 
(World Health Organisation and Collaboration Center for Drugs Statistics 
Methodology, 1998).  
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4.0 Summary of papers 
4.1 Paper I 
 
Reduced mortality in treating acutely sick, frail elderly patients in a geriatric 
evaluation and management unit. A prospective randomized trial. 
 
This paper presents mortality and causes of death in the two groups. 
 
Of 127 patients included in each of the groups, 8 (6%) GEMU and 17 (13%) MW 
patients died during the initial hospital stay (p = 0.002). At three months, mortality was 
15 (12%) and 34 (27%) in the GEMU and MW groups respectively (p = 0.004), at six 
months 20 (16%) and 37 (29%) (p = 0.02), and at 12 months 35 (28%) and 43 (34%) (p 
= 0.06). The reduction in mortality was greatest during the initial three-month period 
with a hazard ratio (HR) 0.39 (95% CI 0.21 – 0.72). Adjustment for age, history of heart 
disease, duration of stay in hospital before inclusion in the study, number of targeting 
criteria and gender in a Cox Proportional Hazard’s Model, did not have any impact on 
HR during the first three months.  
 
For both groups the mortality was highest initially. This was related to the acute 
disorders that precipitated the hospital admission, and then it stabilised after 2-3 
months. The curves came together at 18 months. The median survival was two years in 
both groups. 
 
Heart disease was the major cause of death in both groups at three and 12 months. At 12 
months deaths from infections (mainly pneumonia) were more frequent in the GEMU 
group than in the MW group (p = 0.04).  
 
We concluded that patients treated in the GEMU had a considerable reduction in 
mortality as compared to those treated in the MW. This difference was explained by 
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 higher competence and better organisation of the treatment of acutely sick, frail elderly 
patients in the GEMU as compared to the MW. 
 
4.2 Paper II 
 
Acute geriatric intervention increases the number of patients able to live at home. A 
prospective randomized study. 
 
When designing the present study it was hypothesised that the intervention would 
reduce readmissions to hospital and need of nursing home placement for GEMU 
patients. The aim of the present paper was to compare place of care delivery during six 
months of follow-up in the GEMU and the MW group. 
 
The mean number of days spent in hospital before entering the study was 3.8 (SD 3.7) 
in the GEMU and 4.6 (SD 4.3) in the MW (p = 0.09). The total LOS had a median of 19 
days (iqr 13; 30) in the GEMU group and 13 days (iqr 7; 18) in the MW group (p < 
0.001). The difference in LOS was related to a “delay” during the first five days after 
the patients had been transferred to the GEMU.  
 
There were no statistically significant differences in discharge destination in the two 
groups. After the index stay 73% of the GEMU and MW patients were discharged 
home, 13% of the GEMU and 14% of the MW patients to nursing homes, the rest to 
rehabilitation institutions or other hospital departments. At three months 91% of the 
GEMU and 88% of the MW patients were living at home. At six months 86% in both 
groups lived at home.  
 
Of all patients recruited to the study, 101 (80%) GEMU and 79 (64%) MW patients 
were living at home at three months (p = 0.005), and at six months the numbers were 91 
(72%) and 74 (60%) (p = 0.04). The HR of living at home versus living in nursing 
homes or having died, was 2.1 (95% CI 1.3 - 3.4) after three months, and 1.6 (95% CI 
1.1 - 2.5) after six months.  
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After the index stay, there was no statistically significant differences in readmissions, 
time to nursing home placement, proportion of observed time spent in hospital and 
nursing homes, percentage of patients with transitory or permanent nursing home 
placement, number of days spent in nursing homes and percentage of patients receiving 
assistance from the community nurses. 35% of the GEMU and 31% of the MW patients 
were not admitted to any kind of institutions during six months of follow up. 
 
The main conclusion was that an increased number of GEMU patients were able to live 
in their own homes in contrast to being dead or living in nursing homes during six 
months of follow-up, an effect that was mainly related to the considerably reduced 
mortality in the GEMU group. Patients treated in the GEMU had increased LOS.  
 
4.3 Paper III 
 
Randomised trial of in-hospital geriatric intervention: Impact on function and 
morale. 
 
The aim the present article was to describe the impact of treatment in the GEMU as 
compared to MW on ADL, IADL, cognitive function, symptoms of depression and 
general well-being during one year of follow-up.  
 
Barthel Index and the Lawton instrumental IADL scale were used to assess physical 
function, MMSE to assess cognition, MADRS to screen for symptoms of depression 
and PGCMS to assess general well-being. 
 
The mean scores for MMSE, PGCMS, Barthel Index and IADL did not differ during 
follow up, indicating that cognitive function, general well-being, ability to perform 
ADL and IADL were similar in the two groups. There was no difference in number of 
patients with symptoms of depression. 
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 If the dead were given a Barthel Index score of zero and included in the analysis, there 
was better function in the GEMU group at three months (p = 0.03). 
 
In conclusion, there was no significant difference in ADL, IADL, cognition, symptoms 
of depression or general well-being between those who survived after GEMU and MW 
treatment respectively. A significant reduction in mortality may theoretically lead to 
decreased function and general well-being among the survivors in the GEMU group if 
life was prolonged in those who were at the highest risk of death and morbidity. Hence, 
the findings of no difference between the GEMU and MW survivors were regarded as 
positive. 
 
4.4 Paper IV 
 
Patterns of drug prescription in a geriatric evaluation and management unit as 
compared with the general medical wards. A randomised study. 
 
The aim of this paper was to study if patients treated in the GEMU had a more 
appropriate drug profile than patients treated in the MW. The analyses were based upon 
prespecified hypotheses. Due to multiple comparisons a p-value < 0.01 was regarded as 
statistically significant. 
 
There were no statistically significant differences in the median number of drugs used 
per patient, or in the number of patients with polypharmacy (defined as using 5 or more 
drugs concurrently), neither at inclusion nor at discharge. More scheduled drugs were 
withdrawn per patient from inclusion to discharge in the GEMU (p = 0.005). There was 
also a trend for more drugs being started in the GEMU than in the MW (p = 0.03). At 
discharge fewer GEMU patients had potential drug-drug interactions (DDIs) (p = 
0.009). There was a trend for more MW patients using anticholinergic drugs at 
discharge (p = 0.03), more drugs with anticholinergic effects were withdrawn in the 
GEMU than in the MW (p = 0.003). 
 
 50
 There were 60 withdrawals of cardiovascular drugs in the GEMU as compared to 13 in 
the MW (p < 0.001). Digitalis glycosides were withdrawn in 14 (12%) GEMU patients 
and none of the MW patients (p < 0.001). There were 33 withdrawals of psychotropic 
drugs in the GEMU as compared to nine in the MW (p = 0.009). On the other hand 35 
prescriptions of psychotropic drugs were started in the GEMU as compared to 16 in the 
MW (p = 0.02). In the GEMU 14 antipsychotic prescriptions were withdrawn as 
compared to two in the MW (p = 0.009). Treatment with antidepressants was started in 
20 GEMU patients and in two MW patients (p < 0.001). At discharge more GEMU 
patients used drugs with effect on the uro-genital system/sex hormones than in the MW 
(p = 0.001). This was related to treatment with oestriol which was started in 15 GEMU 
patients as compared to one MW patient (p = 0.001), and was used by 25% of the 
female GEMU patients and 4% of the female MW patients at discharge (p < 0.001).  
 
We concluded that there were distinct differences in prescribing patterns between the 
GEMU and MW. Based upon literature review and clinical recommendations, the 
patterns of prescribing in the GEMU seemed to be more appropriate than in the MW.  
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 5.0 Discussion 
This thesis presents the first study to show that treatment of acutely sick, frail elderly 
patients in a GEMU may significantly reduce mortality and improve the chance of 
living in own home versus being dead or living in nursing homes as compared to 
traditional treatment in MW. There was no difference in care delivery after the hospital 
stay or in function and morale during follow-up, which was also considered a positive 
finding because prolonged survival among frail elderly patients might theoretically 
result in poorer average function and morale. Patterns of drug prescribing in the GEMU 
seemed to be more appropriate than in the MW. 
 
5.1 Comparison with other studies 
5.1.1 Setting 
To our knowledge a total of eight RCTs assessing treatment of hospitalised high-risk 
elderly patients in GEMUs have been published (Rubenstein et al., 1984; Applegate et 
al., 1990; Harris et al., 1991; Landefeld et al., 1995; Asplund et al., 2000; Counsell et 
al., 2000; Cohen et al., 2002; Saltvedt et al., 2002) (Table 1). In addition to our study 
there was one RCT from Sweden (Asplund et al., 2000), and none from other parts of 
Europe. Five RCTs were performed in USA where the health care system is quite 
different from ours, making comparisons difficult regarding characteristics of patients 
referred to the hospitals, use of long-term beds and management of patients.  
 
In general, the studies can either be categorised into those treating patients with acute 
disorders that are not stabilised (Harris et al., 1991; Landefeld et al., 1995; Asplund et 
al., 2000; Counsell et al., 2000) or those treating patients in the subacute stage of the 
disease (Rubenstein et al., 1984; Applegate et al., 1990; Cohen et al., 2002). The setting 
in our study was mixed, where 60% of the patients were included within three days, 
while 18% were included one week or more after admission. 
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 5.1.2 Patient recruitment 
In our study and the three studies performed in subacute settings (Rubenstein et al., 
1984; Applegate et al., 1990; Cohen et al., 2002) patients were targeted for frailty 
before inclusion. However, criteria for frailty varied between the studies. Patients who 
were too healthy, nursing home patients, patients with severe dementia and patients 
with terminal illnesses were excluded in all studies. Rubenstein aimed at including 
patients having “problems that interfered with discharge home” (Rubenstein et al., 
1984). In the study of Applegate  patients having reversible functional impairment 
defined as not being able to perform one or more ADL were included (Applegate et al., 
1990). The targeting criteria used by Cohen were overlapping with those in our study, 
including patients with falls/mobility problems, nutritional problems, cognitive 
impairment, depression, urinary incontinence, prolonged bedrest, and problems in 
performing one or more ADLs (Cohen et al., 2002). In these studies patients were 
recruited from different populations. The percentage of those screened or admitted to 
hospital that were eligible or included to the study varied considerably (Table 1). 
 
A comorbidity index (Knaus et al., 1985; Charlson et al., 1987) or at least the relevant 
diagnoses at inclusion should have been registered at baseline in our study for the 
comparability of our study population with those studied by others. Nevertheless, a 
rough estimate of the case-mix can be obtained by comparing the mortality (Table 1). 
The study of Rubenstein (Rubenstein et al., 1984) had the highest one-year mortality 
with 48% in the control group as compared to 34% in our study. At six months the 
mortality in the control group was 25% in the study of Rubenstein and 29% in ours. In 
the studies of Applegate, Harris, Counsell and Cohen the control group had a one-year 
mortality between 30%, and 21% (Applegate et al., 1990; Harris et al., 1991; Counsell 
et al., 2000; Cohen et al., 2002). In the study of Landefeld and Asplund three-month 
mortality was 13% and 8% respectively (Landefeld et al., 1995; Asplund et al., 2000), 
as compared with 27% in our study. The differences in mortality in these studies 
indicate a considerable variability of case-mix. Except for Rubenstein’s study that had 
lower six-month, but higher one-year mortality, our study had higher mortality at three, 
six and 12 months than the other studies. It is therefore reasonable to believe that our 
study population was sicker than in the other studies. 
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Two of the studies on efficacy of treatment in GEMUs were performed in US Veteran 
Administration hospitals, nearly all participants being male (Rubenstein et al., 1984; 
Cohen et al., 2002). The other studies, including ours, had a majority of female patients. 
We recruited patients of 75 years or older, while the three studies performed in a 
subacute setting recruited patients of 65 years or older (Rubenstein et al., 1984; 
Applegate et al., 1990; Cohen et al., 2002). Those in acute care settings recruited 
patients of 70 years or older (Harris et al., 1991; Landefeld et al., 1995; Asplund et al., 
2000; Counsell et al., 2000). The highest mean age at inclusion was found in our study 
with 82 years, while the study of Cohen had the lowest mean age of 74 years (Cohen et 
al., 2002). 
 
5.1.3 Patient treatment 
The medical treatment programs in the GEMUs seemed to be organised differently. In 
Norway geriatric medicine is a branch specialty of internal medicine, while in USA and 
Sweden it is an independent speciality. In our study the geriatricians were responsible 
both for the acute medical treatment and for the geriatric assessment and management. 
In the study of Asplund  the internists were responsible for the acute medical treatment 
in both the intervention and control groups, while the geriatrician was responsible for 
the CGA (Asplund et al., 2000). In the studies of Landefeld and Counsell attending and 
resident physicians provided treatment to both groups; in addition the GEMUs had 
geriatricians employed (Landefeld et al., 1995; Counsell et al., 2000). The geriatricians 
in these studies reviewed patients’ medications and procedures, had responsibility for 
practice guidelines, made informal recommendations to attending and resident 
physicians and were consultants to the multidisciplinary team (Palmer et al., 1998). In 
the study of Applegate medical treatment was performed either by doctors in the GEMU 
or by the referring physician (Applegate et al., 1990). 
 
5.1.4 Results 
As in our study Rubenstein showed reduced mortality during follow-up (Rubenstein et 
al., 1984), but the survival curves were completely different in the two studies. 
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 Rubenstein found a difference in survival that was emerging after two months and 
lasting for two years, while in our study the effect was highest initially, and then 
diminished. There is no single explanation for the improved initial survival in the 
GEMU group in our study. However, further analyses have shown no differences in 
survival in the GEMU and MW groups for those who had stayed in the DIM more than 
seven days before inclusion into the study. The combination of targeting frail patients 
with acute illness and the geriatricians being responsible for the acute medical treatment 
may partially explain this result.  
 
Some other studies have shown improved performance in ADL (Rubenstein et al., 
1984; Applegate et al., 1990; Landefeld et al., 1995; Cohen et al., 2002), reduced 
utilisation of nursing home beds (Rubenstein et al., 1984; Applegate et al., 1990; 
Landefeld et al., 1995), and improved morale (Rubenstein et al., 1984) or quality of life 
(Cohen et al., 2002). Lack of baseline registrations and the follow-up assessments being 
performed long time after the intervention, as well as significant differences in 
mortality, will altogether complicate the interpretation of the results in our study.  
 
Although the use of composite outcomes may be regarded as controversial, the dead 
have been included in the analyses of living location (paper II) and function (paper III) 
(Montori et al., 2005). There are mainly two reasons for this: 1) The need of 
implementing the differences in mortality found in the GEMU and the MW groups in 
the analyses. 2) Living at home was used as an endpoint in the meta-analyses of Stuck 
often being used as a reference publication (Stuck et al., 1993). The interpretation of the 
composite outcomes is complicated by a considerable difference in mortality between 
the two groups. Nevertheless, the overall treatment effect seems to be positive because 
more patients were able to live at home in contrast to being dead or in nursing homes, 
and more GEMU patients were independent in ADL in contrast to being dependent or 
dead. 
 
The only study showing reduced LOS in the GEMU as compared to the DIM was 
performed by Asplund (Asplund et al., 2000). In our study the mean LOS in the GEMU 
was longer than in the MW (21 versus 12 days). The three studies performed in 
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 subacute settings all had longer LOS in the intervention group than in the control group, 
and their LOS is even longer than in our study (Rubenstein et al., 1984; Applegate et 
al., 1990; Cohen et al., 2002). In the four studies recruiting acutely sick patients, the 
LOS was ten days or shorter in both the intervention and the control groups (Harris et 
al., 1991; Landefeld et al., 1995; Asplund et al., 2000; Counsell et al., 2000). In our 
study the GEMU staff did not focus explicitly on shortening the LOS per se. Rather 
delivering high-quality health care was the ultimate goal. As shown in paper II the 
increased LOS was partly related to a delay associated with transfer of patients to the 
GEMU and the fact that the staff of the GEMU performed study-related assessments. 
Later the LOS in the GEMU has been shortened to about mean 14 days, which is still 
longer than in the acute care studies.  
 
However, performing CGA, discharge planning and starting rehabilitation is all time-
consuming. It is also recommended that drug prescribing in elderly should “start low 
and go slow”, which in many cases mean that time until disorders are successfully 
treated will be prolonged. In addition, it is well known that many patients experience 
decline in function related to hospitalisation for acute disorders and therefore need time 
and help to recover (Fortinsky et al., 1999). 
 
The survival curves in both groups in our study showed high mortality during the first 
two to three months, then it stabilised. In addition, we found that two thirds of the 
patients in both groups had been readmitted to the hospital or admitted to nursing homes 
during six months of follow-up. Therefore it can be concluded that those discharged 
from hospital in this study were still highly unstable and vulnerable. The most logical 
approach would therefore be to 1) Establish optimal post-discharge follow-up. 2) Focus 
on shortening down LOS (Young and Philip, 2000).  
 
Pharmacotherapy has not commonly been used as an endpoint in most RCTs of 
treatment in GEMUs, although there are a few exceptions (Rubenstein et al., 1984; 
Counsell et al., 2000; Schmader et al., 2004). In our study we found distinct differences 
in prescribing between the GEMU and MW. We have hypothesised that the differences 
may be of clinical importance, but we do not have data to confirm these hypotheses. In 
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 general, drug prescribing in the elderly is challenging due to both the complexity of the 
patients as well as the lack of evidence on drug treatment in this patient population 
(Wyller, 2003). Further research is needed to achieve guidelines that can improve 
medical treatment of frail elderly.  
 
5.2 Internal validity 
Internal validity of a trial implies that the differences observed between the intervention 
and control groups may be attributed to the treatment under investigation and not 
random errors (Juni et al., 2001). Internal validity is threatened by bias that fall into four 
categories: Selection bias (comparability of the groups), performance bias (unequal 
provision of care apart from treatment under evaluation), detection bias (biased 
assessment of outcomes) and attrition bias (deviations from the protocol and loss to 
follow-up) (Juni et al., 2001). Although the major strengths of our study are its 
originality and randomised design, similar to others we experienced that performing 
research on frail elderly patients may be challenging (Berkman et al., 2001; Zermansky, 
2005), and of course this study has limitations.  
 
5.2.1 Comparability of the groups 
The randomisation procedure was carefully planned before the study started and has 
also been carefully evaluated afterwards. Although computer generated randomisation 
would have been chosen today, the method used in our study was established practice at 
the time of study planning. The method used was satisfactory regarding the sequence 
generation, allocation concealment and implementation. The aim of randomisation is the 
creation of groups that are comparable for any known or unknown potential 
confounding factor. When randomisation is effective, baseline prognostic factors should 
be distributed equally (Altman and Dore, 1990).  
 
In the present study there were no statistically significant differences in baseline 
characteristics and previous diagnoses, except for fewer GEMU than MW patients using 
drugs for cardiovascular disease at inclusion (Table 5). There were also fewer GEMU 
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 than MW patients with cardiovascular diagnoses from previous stays in the hospital (not 
statistically significant). These differences could theoretically be of prognostic 
importance. However, there was no difference in number of patients with cardiovascular 
diagnoses at discharge.  
 
Because Barthel Index and MMSE are important prognostic factors for mortality, they 
were planned to be baseline characteristics (Campbell et al., 2004). The assessments 
performed during the index stay revealed statistical significantly lower scores for 
MMSE and Barthel Index in the MW group than in the GEMU group. However, as 
described in the methods section, both the methods, timing and setting for these 
assessments were systematically different in the two groups. It is therefore reasonable to 
believe that differences in MMSE and Barthel Index were biased by the design of the 
study.  
 
Roberts and Torgerson have claimed that baseline tests of imbalance are inappropriate 
unless the investigators suspects that there are problems with the randomisation 
(Roberts and Torgerson, 1999), which we do not think is the case in this study. Hence, it 
should not be necessary to adjust the analysis for differences in baseline values. 
However, although randomisation is properly performed, sometimes imbalance can 
occur by chance (Altman and Dore, 1991). Because all differences go in disfavour of 
the MW group which could theoretically explain the differences found in mortality, 
regression analyses have been done where previous cardiovascular disorder or use of 
cardiovascular drugs were imputed as controlling variables. However, this did not affect 
the results of the survival analyses. After imputation of MMSE and Barthel Index scores 
in the Cox regression model, there was still a significant reduction in three-month 
mortality in the GEMU group, confirming the validity of our results.  
 
5.2.2 Outcomes 
In general, assessments of frail elderly patients will be complicated by slow 
communication due to hearing loss or cognitive impairment, and it will be more time-
consuming than for younger patients. Many patients get easily exhausted and some may 
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 even be embarrassed by for example questions assessing cognition or quality of life. 
Therefore the test batteries chosen and the order of testing should take these aspects into 
consideration (Kane, 2000). It is a growing interest towards use of specific and 
subjective assessments instruments for elderly patients that are shorter and can be used 
both for patient and proxy ratings (Kaasa and Loge, 2004). 
 
Assessment instruments should also fulfill certain properties. 1) They should be valid, 
i.e. measure what they purports to measure. 2) They should be reliable, i.e. give similar 
results for different observers and when measurements are repeated (Bland and Altman, 
2002). 3) They should be able to detect changes over time (responsiveness). Instruments 
used for screening of certain conditions should also have high sensitivity i.e. be able to 
detect a condition when it is there, and they should have high specificity i.e. be able to 
correctly state that the condition is absent (Kane, 2000). 
 
Group assignment in this study was not, and could not, be blinded for patients and 
caregivers. Information about the project was given in a neutral way and participants 
were not informed about expectations for outcomes (Schulz et al., 2002). However, the 
assessors should have been a few persons not involved in the management of the 
patients and blinded for the outcomes, which was not the case.  
 
Outcomes evaluated were chosen according to the aims of the study and on the basis of 
findings from other studies. Mortality is easy to count and to compare between settings. 
From a clinical perspective reduced mortality per se is not the main goal in the 
treatment of frail elderly patients, but it may reflect the quality of medical treatment. For 
sample size estimations at the time of study planning it seemed to be the only possible 
endpoint for which some reliable data existed (Donaldson et al., 1980; Booth et al., 
1983).  
 
Place of care delivery is an indirect measure of the patients’ function and health status 
and is important both from the patients’ and health care managers’ perspective. The 
intention of this study was to study place of care delivery during 12 months of follow-
up. We succeeded in collecting data for six months of follow-up, while the data 
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 collected for the last period were disregarded due to inferior quality. Although the data 
published have satisfactory quality, an underestimation of short term stays in nursing 
homes may have occurred.  
 
The main goal of comprehensive geriatric assessment is to achieve the patients’ best 
possible health, highest level of function and quality of life (Elon et al., 2000). 
Therefore, function and quality of life were adequate endpoints. As the patient group 
studied was very heterogeneous, generic measures were chosen instead of condition 
specific instruments. Assessment scales that had been used in other studies and were 
recommended by the British Geriatric Society were applied (Dickinson, 1992). 
 
Physical function was assessed by the use of Barthel Index and Lawtons IADL scales 
(Mahoney and Barthel, 1965; Lawton and Brody, 1969). In Barthel Index some items 
on mobility are incorporated (moving from wheelchair to bed, walking on level surface, 
climbing stairs). Further assessment of mobility would have been relevant because 
patients with mobility problems were targeted for the study, and the intervention in the 
GEMU had focus on physical training (Pearson, 2000).  
 
Barthel Index was developed as a measure of disability in patients with neuromuscular 
and musculoskeletal conditions receiving inpatient rehabilitation (Mahoney and Barthel, 
1965). It is simple to administer and easy to score for trained assessors (Pearson, 2000). 
It has been criticised because it has ´floor´ and ´ceiling´ effects and might be insensitive 
to changes over time (Bowling, 2001; Pearson, 2000). The instrument is designed for 
observation, while in our study both observation, patient and proxy interviews were 
used (Ranhoff and Laake, 1993). Collin  has shown that interviews with nurses or 
relatives are as reliable as observations (Collin et al., 1988). Others have shown that 
self-report is less valid in the very old patients, those with cognitive impairment and 
those with recent changes in ADL (Sager et al., 1992; Sinoff and Ore, 1997). The 
reliability has been well documented for stroke patients (Bowling, 2001). There are few 
studies on reliability in frail elderly patients in general. In a systematic review 
Sainsbury concluded that further studies are justified to investigate reliability for older 
people in general (Sainsbury et al., 2005). The factor structure of the scale is uni-
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 dimensional in stroke patients while two dimensions have been found among geriatric 
patients (Laake et al., 1995). 
 
Lawtons IADL scale (Lawton and Brody, 1969) was originally designed to be used as a 
guide to determine the most appropriate living arrangement for elderly persons. It 
measures three areas: household chores, mobility related activities and cognitive 
activities. Loss in one or more IADLs has been shown to be a potential marker of frailty 
(Nourhashemi et al., 2001), and IADL is frequently used as a measure of function in 
studies with elderly people. Gender and cultural biases have been found. The Lawton 
IADL scale has been criticised because there are inconsistencies in scoring of single 
items in the instrument. Although it has been widely recommended for use, there have 
been few reports on reliability and validity for use of this questionnaire among frail 
elderly patients (Pearson, 2000).  
 
Cognitive impairment was assessed by MMSE that is probably the most widely used 
screening test for cognitive impairment. It is quick and simple to use, and test-retest and 
inter-rater reliability has been shown to be satisfactory (Langley, 2000; Burns et al., 
2004). A cut-off of 23 points is frequently chosen because of optimised sensitivity and 
preserved moderate to high specificity for screening of dementia. Strict cut-off values 
have utility for research, but not for clinical purposes. MMSE has higher sensitivity for 
demented patients than for patients with lower levels of cognitive dysfunction (Langley, 
2000). Although MMSE is widely used in studies as a screening instrument for both 
dementia and delirium (Hjermstad et al., 2004), it is best validated for dementia (Smith 
et al., 1995). When working with hospitalised elderly patients it is important to 
differentiate between dementia and delirium, and today additional instruments for 
screening of delirium could have been chosen, for example the Confusional Assessment 
Methods (CAM) (Laurila et al., 2002; Inouye, 2004;). 
 
Symptoms of depression were assessed by MADRS (Montgomery and Asberg, 1979). 
This scale has been demonstrated to be a sensitive measure of change when studying 
treatment for depression, and the reliability and validity has been shown to be 
satisfactory (Burns et al., 2004). MADRS have been recommended for use among 
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 geriatric patients in the Nordic countries (Sletvold et al., 1996). However, during the 
last years the Geriatric Depression Scale (GDS) has been recommended for use among 
geriatric patients who are not or moderately cognitively impaired (Yesavage et al., 
1982; Watson and Pignone, 2003). Shortened versions of GDS has been evaluated and 
found to be reliable and valid, and it seems that the five items version can now 
recommended for clinical use and research (Almeida and Almeida, 1999; Hoyl et al., 
1999). 
 
Quality of life was assessed by the PGCMS (Lawton, 1975; Morris and Sherwood, 
1975), which is actually measuring morale. Although the PGCMS has been widely 
recommended for use in geriatric populations (Dickinson, 1992), intact cognition is 
required to answer many of its items. The trend within clinical research is to measure 
health related quality of life that would be most influenced by health and health care 
interventions (Kaasa and Loge, 2002), and an instrument such as SF-36 (Ware, Jr. and 
Sherbourne, 1992) might have been suitable to measure the effect of the intervention 
given in the GEMU.  
 
5.2.3 Performance 
All patients randomised to the GEMU group were treated in the GEMU during the 
initial stay. If they were readmitted to the hospital during the period of follow-up, they 
were treated in the MW. None of the patients randomised to the MW were treated in the 
GEMU neither during the initial hospital stay nor during the period of follow-up.  
 
To evaluate the effect of the intervention it would be optimal if the patients in the MW 
were not seen by the staff in the GEMU. On the other hand, it was unethical to resist 
any evaluation of these patients. Therefore, in concordance with general 
recommendations (Feussner et al., 1991), study patients could be referred to 
consultation by a geriatrician if the doctor responsible for the patient found it indicated, 
either during the index stay or later. These patients got the same type of consultation 
and advice as patients not included in the study.  
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 During standardised follow-up assessments patients occasionally presented clinical 
problems. These were then described in a letter to the GP who was responsible for 
follow-up. For ethical reasons clinical problems that could be characterised as 
emergencies were initially handled by the GEMU physician, until someone else could 
take responsibility.  
 
The impact of these factors on the results of the study is unknown. RCTs on 
consultation teams in hospital have shown little or no effects on the outcomes relevant 
for the present study (Stuck et al., 1993; Naughton et al., 1994; Reuben et al., 1995). In 
our study, single patients were seen by the geriatrician and not by a team. We hardly 
think this influenced the results.  
 
5.2.4 Attrition 
The compliance was over 80% for all assessments, except for the PGCMS for which it 
was somewhat lower. We considered this to be satisfactory, because low attrition is a 
well-known problem when studying a group of patients who are sick and disabled 
(Jordhoy et al., 1999). As described in the method chapter, different methods were used 
to handle missing values. We concluded that only extreme differences between those 
who were lost to follow-up in the two groups would have had impact on the results of 
the study. As patients who withdrew or were lost to follow up in the two groups did not 
differ with respect to age, gender, living location after three months, or one-year 
survival, there is no reason to believe that the reduced compliance had substantial 
impact on the results. 
 
When recruiting patients for the study there was one violation of the protocol: A few 
times there were no eligible patients 75 years or older. Being part of a busy department 
the GEMU was not allowed to keep beds free to wait for study patients. Therefore, five 
patients between 72 and 74 were included (two in the GEMU and three in the MW 
group). Apart from age these patients met the inclusion criteria of the study. Analyses 
have been performed both with these included or excluded which made no differences.  
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 5.3 External validity 
External validity (generalisability) of the trial is the extent to which results of trials 
provide a correct basis for generalisation to other circumstances (Juni et al., 2001). As 
this was a single centre study the external validity may be difficult to interpret. 
 
The study was meant to be “naturalistic” i.e. patients included should as far as possible 
reflect sick, frail elderly patients that are frequently admitted to hospital. Therefore the 
inclusion criteria were broad. Of all emergency admissions among patients 75 years or 
more with living location in Trondheim, 18% were included. In addition to the formal 
exclusion criteria (Table 3) patients were not included if there was no free bed in the 
GEMU. In addition, the Stroke Unit at the DIM had an ongoing trial (Indredavik et al., 
2000). Therefore stroke patients were only included if they would not receive treatment 
in the Stroke Unit and had problems additional to their stroke. The exclusion of patients 
due to lack of beds could hardly have any impact on the generalisability. However, the 
results of this study are not applicable for acute stroke patients.  
 
Unfortunately we did not screen all patients admitted to the DIM and therefore do not 
know the exact proportion of patients who would have been eligible (Moher et al., 
2001). After the study was finalised the prevalence of “geriatric” patients in the DIM 
was studied through a one-day prevalence study (criteria used were largely overlapping 
with those used in the present study). It was estimated that about 30% of patients of 75 
years or older staying at the DIM were in need of treatment at the GEMU. In 1998 a 
similar national one-day prevalence study of patients over 75 years at 59 Norwegian 
medical departments was performed (Rø, 2000). It was shown that of 4234 patients, 
1781 (42%) were 75 years or older. These patients were characterised by many relevant 
diagnoses concurrently. In addition, a considerable proportion had impaired cognitive 
and/or physical function. In the study of Rø it seemed to be differences in case-mix 
when comparing the larger hospitals with established geriatric services and hospitals 
without such services (mostly smaller hospitals) (Rø, 2000). It was concluded that the 
larger hospitals had sicker patients than the smaller hospitals, although the number of 
patients treated for terminal illness was higher in the smaller hospitals. The need of 
geriatric treatment for the patients was defined by each department, which estimated 
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 that 21 % of all patients would profit from geriatric treatment. The proportion was 30% 
in hospitals that had established geriatric services. Reuben found that 35 % of the 
hospitalised patients over 65 years would be appropriate for comprehensive geriatric 
assessment (Reuben et al., 1992). Based upon these results we have concluded that 
probably about 30% of all patients over 75 years admitted to the DIM at our hospital 
and other larger hospitals would benefit from treatment in a GEMU.  
 
The MW patients in this study were treated in highly specialised sections at the DIM of 
a university hospital. Regarding generalisability we do not know if the quality of care 
for frail elderly patients differs between highly specialised university hospitals and 
smaller hospitals, not so specialised.  
 
CGA is kind of “black box” treatment. Although there is evidence that assessment and 
treatment of many of its components are efficient, other factors such as competence of 
the staff, physical environment, traditions within different hospitals or countries, may 
influence the outcomes measured. Our GEMU was localised within a medical 
department with mostly non-elective admissions and patients with acute medical 
illnesses. Acute medical treatment was an important part of the intervention and had 
priority, CGA was performed when the patients were medically stabilised. The role of 
the geriatricians seem to have been somewhat different in some of the other studies. It is 
impossible to answer the question on whether “our “ type of intervention can be 
implemented into GEMUs that are not part of internal medicine.  
 
5.4 Are the results still relevant? 
Geriatric medicine had been introduced as a GEMU at the University hospital of 
Trondheim shortly before the study took place, and the study was initiated because it 
was important to assess efficacy of treatment in the GEMU. With hindsight it is obvious 
that today the treatment offered in the GEMU is better and more developed than it was 
during the study period. It is reasonable to believe that certain conditions such as silent 
delirium and mild dementia may have been underdiagnosed, and also that the function 
of the interdisciplinary team sometimes might have been suboptimal. Based upon the 
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 experiences that the patients often were unstable after discharge, we have recently 
established a team for transitional care that focus on the first four weeks after discharge 
from hospital. In general, the attitude towards frail elderly patients in our hospital seems 
to have improved today as compared to 10 years ago. It is also fair to say that due to 
continuous educational programs both for doctors and nurses on treatment of frail 
elderly patients, the competence in handling conditions like delirium is probably better 
now.  
 
Although recent studies show that older patients are getting better treatment for 
common diseases there is still evidence that care offered to elderly patients is less than 
optimal for general medical conditions, and even more so for geriatric giants (Reuben et 
al., 2003; Wenger et al., 2003). The case-mix and targeting of patients obviously are 
important predictors of treatment effects. It should be noted that no RCT except ours 
has shown reduced mortality by treating geriatric patients with acute conditions in a 
GEMU. Possible explanations for the positive results in our study may be linked to: 1) 
The geriatrician had responsibility both for the acute medial treatment and for the CGA. 
2) The patients were older and sicker and also characterised by increased frailty as 
compared to the other studies. Therefore, due to demographic and epidemiological 
trends, our findings may become even more relevant in the future indicating a need of 
transferring geriatric competence into the acute medical care for the elderly.  
 
Focus on specific competence and organisation may also explain some of the beneficial 
effects shown in our study. In our hospital three other studies have been performed that 
have shown beneficial effects of improving competence and organisation in the care of 
previously neglected groups of patients. A cluster randomised study showed that a 
palliative care intervention enabled more patients with advanced cancer to die at home 
as compared to traditional care (Jordhoy et al., 2000). Two RCTs on treatment of 
patients with acute stroke have shown that treatment in a Stroke Unit was beneficial as 
compared to traditional treatment in the DIM and that an extended stroke unit service 
with early supported discharge improved functional outcome and reduced the length of 
hospital stay compared to traditional stroke unit care (Indredavik et al., 1991; 
Indredavik et al., 2000). This also is in accordance with results from other studies 
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 showing that only treatment in specially organised wards has beneficial effects on 
outcomes (Stuck et al., 1993; Langhorne et al., 2005), while consultation by specialised 
teams has no effects. It is therefore reasonable to believe that CGA can best be 
performed in special settings like the GEMU, supporting the findings in our study. 
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 6.0 Conclusion 
o Mortality in the GEMU and MW groups respectively was 12% and 27% at three 
months (p = 0.004), 16% and 29% (p = 0.02) at six months, and 28% and 34% (p = 
0.06) at 12 months. The HR for the difference in mortality was 0.39 (95% CI 0.21 – 
0.72) at three months. Heart disease was the major cause of death in both groups at 
both three and 12 months. At 12 months deaths from infections (mainly pneumonia) 
were more frequent in the GEMU group.  
o The LOS in the GEMU was longer than in the MW. There was no difference in 
place of care delivery in the two groups after discharge from hospital during six 
months of follow-up. Of all subjects recruited to the study, more GEMU than MW 
patients were still living in their own homes at three and six months, an effect that 
was mainly related to considerably reduced mortality in the GEMU group. It was 
concluded that there was an overall positive effect of treating acutely sick, frail 
elderly in a GEMU. 
o  Treatment in the GEMU had no measurable effect on ADL, IADL, cognitive 
function, symptoms of depression or morale during 12 months of follow- up. If the 
dead were included in the analyses at the highest ADL dependency level, there was 
better function in the GEMU group at three months. Taken the previously shown 
mortality reduction into consideration, an additional effect on function was less 
likely and the overall treatment effect was considered to be positive.  
o The median number of scheduled drugs withdrawn per patient was higher in the 
GEMU than in the MW. Drugs with anticholinergic effects, cardiovascular drugs, 
particularly digitalis glycosides, and antipsychotic drugs were withdrawn more often 
in the GEMU.  There was a trend for more scheduled drugs being started in the 
GEMU than in the MW. In particular antidepressants and oestriol were started more 
often. Fewer GEMU than MW patients had potential drug-drug interactions at 
discharge. The number of patients with polypharmacy did not differ significantly 
between the GEMU and MW. It was concluded that drug treatment in the GEMU 
seemed to be more appropriate than in the MW. 
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 o The survival curves in both groups show increased mortality during two to three 
months after inclusion in the study. Two thirds of the patients in both groups had 
been admitted to nursing homes or readmitted to hospital during six months of 
follow-up. In can therefore be concluded that these high risk patients in the future 
would need further attention. 
o This trial is one of relatively few in this area probably because such studies are 
difficult to conduct. It may serve as an example of the complexity of carrying out an 
adequate trial on geriatric management. It exemplifies the importance of performing 
rigorous checks that the randomisation has been effective. Ideally, assessors should 
be blinded to the allocation, and it is essential that the randomised groups are 
managed and assessed in an identical manner. The protocol should be explicit about 
the time of assessment and standardisation of methods. 
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7.0 Areas for future research 
There is a major need for scientifically rigorous RCTs to demonstrate convincingly the 
benefits of different geriatric management policies in general. Geriatric research should 
be performed in acute care settings, on home-dwelling elderly and nursing home 
residents. Research on how to organise post discharge follow-up to make sure that 
patients are not falling between the cracks will also be important.  
 
To be able to target the right intervention to the right patient and streamline the CGA 
process, further research is needed to find valid tools to predict the prognosis of 
geriatric patients. Still much is unknown about both the process of care including 
staffing, environmental issues, discharge planning and single components of CGA and 
their impact on the patients’ function and quality of life. Studies involving the patients’ 
and caregivers’ preferences are also lacking. Frail elderly patients have been excluded 
from clinical trials of drug treatment, thus further research is needed to investigate 
strategies for optimal drug treatment in such patients.  
 
Making RCTs on very old patients with many chronic disorders are challenging. 
Alternative methods should therefore be considered in addition to RCTs, using quality 
indicators or establishing high-quality databases with equal datasets within and across 
countries. The Resident Assessment Instrument (RAI) is an example of a dataset that 
has been recommended for use among geriatric patients (Phillips et al., 1997). Such 
databases may improve possibilities for assessing case-mix, care plans, outcome 
measures and quality measures. 
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